Global Influenza Diagnostics 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI03253557

Publication Date:

March 21, 2025

Pages:

101

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Influenza Diagnostics market size is predicted to grow from US$ 2726 million in 2025 to US$ 3985 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
The 鈥淚nfluenza Diagnostics Industry Forecast鈥� looks at past sales and reviews total world Influenza Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Influenza Diagnostics sales for 2025 through 2031. With Influenza Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Influenza Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Influenza Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Influenza Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
RIDT
RT-PCR
Cell Culture
Others
Segmentation by Application:
Hospitals
POCT
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Influenza Diagnostics 麻豆原创 Size (2020-2031)
2.1.2 Influenza Diagnostics 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Influenza Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Influenza Diagnostics Segment by Type
2.2.1 RIDT
2.2.2 RT-PCR
2.2.3 Cell Culture
2.2.4 Others
2.3 Influenza Diagnostics 麻豆原创 Size by Type
2.3.1 Influenza Diagnostics 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Influenza Diagnostics 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Influenza Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Influenza Diagnostics 麻豆原创 Size by Application
2.5.1 Influenza Diagnostics 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Influenza Diagnostics 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Influenza Diagnostics 麻豆原创 Size by Player
3.1 Influenza Diagnostics 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Influenza Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Influenza Diagnostics Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Influenza Diagnostics Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Influenza Diagnostics by Region
4.1 Influenza Diagnostics 麻豆原创 Size by Region (2020-2025)
4.2 Global Influenza Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Influenza Diagnostics 麻豆原创 Size Growth (2020-2025)
4.4 APAC Influenza Diagnostics 麻豆原创 Size Growth (2020-2025)
4.5 Europe Influenza Diagnostics 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Influenza Diagnostics 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Influenza Diagnostics 麻豆原创 Size by Country (2020-2025)
5.2 Americas Influenza Diagnostics 麻豆原创 Size by Type (2020-2025)
5.3 Americas Influenza Diagnostics 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Diagnostics 麻豆原创 Size by Region (2020-2025)
6.2 APAC Influenza Diagnostics 麻豆原创 Size by Type (2020-2025)
6.3 APAC Influenza Diagnostics 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Influenza Diagnostics 麻豆原创 Size by Country (2020-2025)
7.2 Europe Influenza Diagnostics 麻豆原创 Size by Type (2020-2025)
7.3 Europe Influenza Diagnostics 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Influenza Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Influenza Diagnostics 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Influenza Diagnostics 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Influenza Diagnostics 麻豆原创 Forecast
10.1 Global Influenza Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Influenza Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Influenza Diagnostics Forecast
10.1.3 APAC Influenza Diagnostics Forecast
10.1.4 Europe Influenza Diagnostics Forecast
10.1.5 Middle East & Africa Influenza Diagnostics Forecast
10.2 Americas Influenza Diagnostics Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Influenza Diagnostics Forecast
10.2.2 Canada 麻豆原创 Influenza Diagnostics Forecast
10.2.3 Mexico 麻豆原创 Influenza Diagnostics Forecast
10.2.4 Brazil 麻豆原创 Influenza Diagnostics Forecast
10.3 APAC Influenza Diagnostics Forecast by Region (2026-2031)
10.3.1 China Influenza Diagnostics 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Influenza Diagnostics Forecast
10.3.3 Korea 麻豆原创 Influenza Diagnostics Forecast
10.3.4 Southeast Asia 麻豆原创 Influenza Diagnostics Forecast
10.3.5 India 麻豆原创 Influenza Diagnostics Forecast
10.3.6 Australia 麻豆原创 Influenza Diagnostics Forecast
10.4 Europe Influenza Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Influenza Diagnostics Forecast
10.4.2 France 麻豆原创 Influenza Diagnostics Forecast
10.4.3 UK 麻豆原创 Influenza Diagnostics Forecast
10.4.4 Italy 麻豆原创 Influenza Diagnostics Forecast
10.4.5 Russia 麻豆原创 Influenza Diagnostics Forecast
10.5 Middle East & Africa Influenza Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Influenza Diagnostics Forecast
10.5.2 South Africa 麻豆原创 Influenza Diagnostics Forecast
10.5.3 Israel 麻豆原创 Influenza Diagnostics Forecast
10.5.4 Turkey 麻豆原创 Influenza Diagnostics Forecast
10.6 Global Influenza Diagnostics Forecast by Type (2026-2031)
10.7 Global Influenza Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Influenza Diagnostics Forecast
11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Influenza Diagnostics Product Offered
11.1.3 BD Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Information
11.2.2 Abbott (Include Alere) Influenza Diagnostics Product Offered
11.2.3 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Abbott (Include Alere) Main Business Overview
11.2.5 Abbott (Include Alere) Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Influenza Diagnostics Product Offered
11.3.3 Roche Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 SIEMENS
11.4.1 SIEMENS Company Information
11.4.2 SIEMENS Influenza Diagnostics Product Offered
11.4.3 SIEMENS Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 SIEMENS Main Business Overview
11.4.5 SIEMENS Latest Developments
11.5 Analytik Jena
11.5.1 Analytik Jena Company Information
11.5.2 Analytik Jena Influenza Diagnostics Product Offered
11.5.3 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Analytik Jena Main Business Overview
11.5.5 Analytik Jena Latest Developments
11.6 Quidel
11.6.1 Quidel Company Information
11.6.2 Quidel Influenza Diagnostics Product Offered
11.6.3 Quidel Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Quidel Main Business Overview
11.6.5 Quidel Latest Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Information
11.7.2 Thermo Fisher Influenza Diagnostics Product Offered
11.7.3 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Thermo Fisher Main Business Overview
11.7.5 Thermo Fisher Latest Developments
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Information
11.8.2 Meridian Bioscience Influenza Diagnostics Product Offered
11.8.3 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Meridian Bioscience Main Business Overview
11.8.5 Meridian Bioscience Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Influenza Diagnostics Product Offered
11.9.3 BioMerieux Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Information
11.10.2 Sekisui Diagnostics Influenza Diagnostics Product Offered
11.10.3 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Sekisui Diagnostics Main Business Overview
11.10.5 Sekisui Diagnostics Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Influenza Diagnostics Product Offered
11.11.3 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Information
11.12.2 SA Scientific Influenza Diagnostics Product Offered
11.12.3 SA Scientific Influenza Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 SA Scientific Main Business Overview
11.12.5 SA Scientific Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.